Queen Tiger
An obscure modern hybrid with thin documentation, mostly known through small-batch breeder claims and dispensary menus.
Queen Tiger is a low-documentation strain. You'll see it on a handful of menus and breeder pages, but there is no peer-reviewed chemistry, no verified lineage record, and no clinical data specific to it. Anything you read about its 'effects' — including the usual indica/sativa framing — is marketing or anecdote. If you're considering it, judge the specific jar in front of you by its lab COA and your own tolerance, not by the name on the label.
Overview
Queen Tiger is a cannabis strain that appears occasionally on dispensary menus and small breeder catalogs but has essentially no presence in scientific literature or major strain databases. We could not verify a breeder of record, an original release date, or a stable genetic profile from independent sources No data.
That puts Queen Tiger in the same category as thousands of other modern hybrid names: a label that may refer to genuinely distinct genetics in one shop and to relabeled flower in another. Without a verifiable seed source or COA history, the name itself is not a reliable signal of what's in the jar.
If you have documentation on this strain (breeder records, original cross, lab data), it would meaningfully improve this entry. We'd rather be short and honest than long and wrong.
Chemistry: cannabinoids and terpenes
We do not have access to a representative set of certificates of analysis (COAs) for Queen Tiger, and no peer-reviewed chemotyping has been published on it No data.
What we can say generally: modern commercial hybrids in legal U.S. and Canadian markets typically test between roughly 15% and 25% THC, with CBD below 1%, based on aggregated state lab data [1][2]. Terpene totals usually fall between 0.5% and 2.5% by weight [1]. Without strain-specific COAs, assume Queen Tiger sits somewhere in this range until a lab report tells you otherwise.
Dominant terpene claims (myrcene, limonene, caryophyllene, etc.) circulate for almost every named strain, but cannabis chemotype varies more by grower, phenotype, and cure than by name [3]. The widely repeated claim that >0.5% myrcene makes a strain 'indica-like' or sedating is folklore, not established pharmacology Disputed[3].
Bottom line: check the COA on the specific batch. The name will not tell you the chemistry.
Reported effects
There is no clinical research on Queen Tiger specifically, and there is no strain-specific clinical research on essentially any named cannabis cultivar No data. Effects you read in marketing copy ('relaxing,' 'uplifting,' 'creative') are aggregated user self-reports from sites like Leafly or AllBud, not measured outcomes.
What the evidence actually supports:
- THC dose, route, and individual tolerance predict subjective effects far better than strain name Strong evidence[4].
- The indica/sativa dichotomy does not reliably predict chemical composition or effects Strong evidence[3][5].
- Set, setting, and prior cannabis experience shape the high substantially Strong evidence[4].
If someone tells you Queen Tiger will reliably make you feel a specific way, they're describing their experience, not a pharmacological property of the strain.
Lineage
We could not verify a parent cross for Queen Tiger from a primary breeder source. Various dispensary write-ups suggest OG Kush–adjacent or Tiger-prefixed parentage, but these claims are not supported by breeder documentation we could confirm No data.
This is the norm rather than the exception for modern strain names. Genetic studies have repeatedly shown that strains sold under the same name often differ substantially in genotype, and strains with different names are often genetically near-identical Strong evidence[5][6]. Treat any lineage claim about Queen Tiger as unverified unless the seller can produce a seed receipt or breeder lineage chart you can independently check.
Cultivation basics
We do not have verified cultivation data for Queen Tiger — no documented flowering time, yield range, or stretch characteristics from a breeder of record No data.
General guidance for an unknown modern hybrid:
- Expect an 8–10 week indoor flowering window; this covers the majority of commercial hybrids Weak / limited.
- Without a known phenotype, run a small test batch before committing canopy space.
- Phenotype hunt: if you're starting from seed and the genetics aren't well-stabilized (likely, given the lack of documentation), expect noticeable variation between plants.
If you obtain clones from a specific source, ask for that grower's logs (veg time, flower time, feed schedule, final dry weight per plant) — that's far more useful than any generic strain page.
Marketing vs. reality
The Queen Tiger name does a lot of work that the underlying product can't verify. A few honest points:
- Name ≠ genetics. Genetic analyses have shown widespread mislabeling across the legal market Strong evidence[5][6]. A jar labeled Queen Tiger in one shop may share little with a jar of the same name elsewhere.
- 'Exotic' branding doesn't predict potency or terpene richness. Aggressive names and tiger-themed packaging are marketing, not chemistry.
- No strain has clinical evidence behind it. Cannabis research generally studies THC and CBD doses, not branded strains Strong evidence[4].
- Trust the COA, not the label. A current lab report with cannabinoids and terpenes tells you more than any strain description, including this one.
If Queen Tiger is in front of you and it smells good, tests clean, and the price is fair, that's a reasonable purchase. Just don't expect the name to predict your experience.
Sources
- Peer-reviewed Smart, R., Caulkins, J. P., Kilmer, B., Davenport, S., & Midgette, G. (2017). Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. Addiction, 112(12), 2167–2177.
- Peer-reviewed ElSohly, M. A., Chandra, S., Radwan, M., Majumdar, C. G., & Church, J. C. (2021). A Comprehensive Review of Cannabis Potency in the United States in the Last Decade. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 6(6), 603–606.
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Government National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press.
- Peer-reviewed Schwabe, A. L., & McGlaughlin, M. E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1, 3.
- Peer-reviewed Sawler, J., Stout, J. M., Gardner, K. M., Hudson, D., Vidmar, J., Butler, L., Page, J. E., & Myles, S. (2015). The genetic structure of marijuana and hemp. PLOS ONE, 10(8), e0133292.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...